KLTOW
Klotho Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.09
−9.28%Price chart
Feb 20Feb 25Mar 2Mar 5Mar 10Mar 13Mar 18Mar 23
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.3x
Market Cap
$5.11M
MomentumView details →
1D Return
−9.28%
YTD Return
−10.32%
RSI (14)
46.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.3x
Market Cap
$5.11M
RSI (14)
46.1
MomentumView details →
1D Return
−9.28%
YTD Return
−10.32%
Similar companies
Latest newsMore news →
Greenland Mines announced it will close its acquisition of Sarfartoq Rare Earths by September 1, 2026, after securing Government of Greenland approval and completing a public offering to fund the deal.8d agoGreenland Mines Ltd signed a Securities Purchase Agreement to sell 1,632,783 shares of common stock and pre-funded warrants for up to 2,367,517 shares at $5.00 per share, expecting net proceeds of approximately $18.5 million, with the offering expected to close on August 27, 2026.9d agoGreenland Mines announced a maiden S-K 1300 economic study for its Sarfartoq Nd-Pr rare earth project in Greenland, valuing the project at up to US$2.05 billion with a pre-tax IRR of 118.6%.11d ago